Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,364.00
Bid: 12,398.00
Ask: 12,400.00
Change: 268.00 (2.22%)
Spread: 2.00 (0.016%)
Open: 12,150.00
High: 12,440.00
Low: 12,134.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

"Early warning signals" as testing demand rises for first time weeks

Thu, 18th Mar 2021 16:18

(Alliance News) - Community demand for coronavirus tests has increased by more than 9% in the last week, the first rise for five weeks, the Health & Safety Executive said.

HSE chief executive Paul Reid said the trend was an "early warning signal" that progress made in bringing down positive case numbers and hospital admissions is stalling.

Reid said there was "some concern" that the daily case numbers are no longer falling as they have been in recent weeks.

He told an HSE briefing on Thursday: "There are early warning signals for us that the brakes are being slightly put on in terms of improvements we've been making over the previous few weeks.

"Because the rate of decrease in hospitalisations for patients with Covid has slowed, particularly over the last few weeks, it's actually stalled.

"And the slowing in reduction of the hospitalised cases mirrors the slowing in reduction of the overall cases happening in the community."

He added: "Community testing demand has increased by over 9% in the past week, community demand for testing has increased for the first time in five weeks.

"That's just one of the early trends, early warning indicators I mentioned earlier on."

In terms of vaccinations however, Reid said the "glass is half full" despite problems with supply and the decision to pause administration of the AstraZeneca inoculation.

The European Medicines Agency is to decide on Thursday whether the AstraZeneca vaccine is safe after its use was paused by a number of European countries, including Ireland.

It followed reports by the Norwegian Medicines Agency of blood clots in a number of patients.

Reid said the decision to pause its use demonstrated the "huge emphasis that we will continuously put on safety of the population".

He added: "Just to reassure, we will respond quickly to whatever decision is recommended, and communicated onwards to us.

"Despite this disappointment we should, in my view, say the glass is half full.

"We have administered around 620,000 vaccinations, and we are witnessing, every day, the collapsing infection rates amongst residents in long-term care facilities, on health care workers and the oldest age groups in the population."

The HSE anticipates that between 70,000 and 75,000 vaccines will be administered next week in the over-70s population.

The health service has now carried out four million coronavirus tests and conducted one million close contact calls.

The seven days up to March 17 saw 3,646 new cases notified, an increase of 6% on the previous week.

Almost 46% of new cases over the past two weeks were among people aged 19 to 44 .

Some 26% of new cases in that period were among children aged 0 to 18 years, and about 8.6% were among people aged 65 years and over.

Reid said: "There are significant signs of stalling in the previously reported progress of cases.

"Numbers of new cases has slightly increased, the reductions in hospitalisations has certainly stalled last week. More positively, the numbers in ICU are reducing."

Over the last 14 days, of the 7,048 new cases notified between March 3 and 16, 6% of them (422) have been admitted to hospital.

Of those, 9% of them were in the age group 0 to 18, with no ICU admissions in that period.

Just over 19% were in the age group 19 to 34 with two ICU admissions.

Almost 33% were in the age group 35 to 64 with four ICU admissions, and around 29% were 65 and over, with seven ICU admissions.

Reid said: "Our hospitals still continue to have significant pressures in relation to Covid and management of Covid.

"We do hope that the progress we have seen in the past few weeks, picks up again in the coming couple of weeks."

On Wednesday, a further 17 deaths of people with coronavirus and another 557 confirmed cases of the virus were notified.

By James Ward, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.